CRISPR-Cas, a robust gene-editing technology in the era of modern cancer immunotherapy
Abstract Cancer immunotherapy has been emerged as a promising strategy for treatment of a broad spectrum of malignancies ranging from hematological to solid tumors. One of the principal approaches of cancer immunotherapy is transfer of natural or engineered tumor-specific T-cells into patients, a so...
Na minha lista:
| Principais autores: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMC
2020-09-01
|
| coleção: | Cancer Cell International |
| Assuntos: | |
| Acesso em linha: | http://link.springer.com/article/10.1186/s12935-020-01546-8 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|